Pharming Group NV (PHARM) — Cash Flow Reinvestment Rate
Pharming Group NV (PHARM) has a Cash Flow Reinvestment Rate of 0.00x as of September 2025, reinvesting €93.00K (capex €70.00K plus investments €23.00K) from operating cash flow of €32.03 Million. Check PHARM operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Pharming Group NV Cash Flow Reinvestment Rate (2017–2022)
Historical reinvestment intensity for Pharming Group NV across 6 annual periods. Explore Pharming Group NV strategic investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Pharming Group NV (2017–2022)
Year-by-year capital reinvestment analysis for Pharming Group NV. For live market cap and broader valuation context, see Pharming Group NV (PHARM) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.41x | €9.28 Million | €22.90 Million | €1.98 Million | ▼ -28.8% |
| 2021 | 0.57x | €20.55 Million | €36.13 Million | €15.96 Million | ▲ +208.0% |
| 2020 | 0.18x | €16.80 Million | €90.98 Million | €16.47 Million | ▼ -51.3% |
| 2019 | 0.38x | €28.25 Million | €74.56 Million | €25.44 Million | ▲ +145.9% |
| 2018 | 0.15x | €7.12 Million | €46.19 Million | €4.31 Million | ▼ -27.6% |
| 2017 | 0.21x | €9.76 Million | €45.84 Million | €7.25 Million | — |